Lecture 7Comprehensive Notes on Enzyme Kinetics, Catalytic Mechanisms, and Metabolic Regulation

Fundamental Constraints of Living Systems and the Role of Catalysis

• The Biosynthetic Hierarchy and the Structure-Function Principle:

  • Living cells construct complex macromolecules from simple metabolic precursors: beginning with glucose, sequential, single-step modifications generate monomers, which are subsequently polymerized into functional macromolecules.

  • The structural arrangement of biological macromolecules directly governs their biochemical function. Predicting molecular structure allows direct prediction of cellular function.

• Three Giant Thermodynamic and Kinetic Challenges to Life:

  • Reaction Velocity: Biochemical reactions must proceed at exceptionally rapid rates. Cellular processes cannot wait hours or days to reach thermodynamic equilibrium. For example, a single bacterial cell must duplicate its entire molecular machinery within a single generation time of approximately one hour. The evolutionary solution to rate acceleration is catalysis by enzymes.

  • Reaction Directionality: Stepwise cellular modifications do not always follow an energetically favorable pathway. Biological systems must actively direct chemical transformations against unfavorable thermodynamic gradients. The solution is metabolism, which generates, couples, and harnesses chemical energy.

  • Information Storage and Heritability: Structural blueprints for catalytic enzymes and metabolic networks must be accurately preserved and transmitted across generations. The molecular solution for hereditary information storage is DNA (introduced in detail by Dr. Abner).

  • Division of Labor: The fundamental challenges of reaction rate and reaction directionality are handled biochemically by proteins.

Thermodynamics and Kinetics of Chemical Reactions

• Thermodynamic Principles of Spontaneous Reactions:

  • Consider the inorganic model reaction between hydrogen gas and iodine gas to form hydrogen iodide:         $H_2 + I_2 \rightleftharpoons 2HI$

  • This reaction is energetically favorable, releasing approximately $3\,\text{kcal/mol}$ of free energy ($\Delta G \approx -3\,\text{kcal/mol}$). The forward reaction proceeds spontaneously toward the right.

  • A "spontaneous" reaction strictly denotes thermodynamic favorability (energy release) and must never be conflated with reaction speed or velocity.

  • Because the reaction is energetically favorable, the system at equilibrium establishes a product-to-substrate ratio of approximately $150$ times more product than reactants.

  • Exergonic Reactions: Reactions characterized by a negative change in free energy ($\Delta G < 0$) release energy and proceed spontaneously in the forward direction.

  • Endergonic Reactions: Reactions characterized by a positive change in free energy ($\Delta G > 0$) require an input of free energy to drive the reaction in the forward direction.

• Free Energy Diagrams and Bond Energies:

  • Free energy coordinates define relative thermodynamic states. Although absolute free energy values cannot be measured, differences in free energy ($\Delta G$) between initial and final states are precisely quantifiable. Lower free energy states correspond to higher thermodynamic stability.

  • Conceptualizing covalent bond restructuring:

    • Complete homolytic cleavage of the $H-H$ and $I-I$ covalent bonds requires an energy investment of approximately $100\,\text{kcal/mol}$.

    • Subsequent formation of the two $H-I$ bonds releases approximately $103\,\text{kcal/mol}$.

    • The net thermodynamic difference accounts for the $-3\,\text{kcal/mol}$ released into the surroundings.

• The Transition State and Activation Energy ($E_a$):

  • Reactions do not proceed via complete, prior dissociation of reactant bonds because the required energetic barrier is excessively high to occur under physiological thermal conditions.

  • Molecules undergo random thermal collisions. Because kinetic energy is unequally distributed across a molecular population, rare, high-velocity collisions provide sufficient energy to form a transient, high-energy transition state.

  • In the transition state, electrons become delocalized across all reacting atoms, forming transient, partial bonds simultaneously among the four atomic centers.

  • The transition state is exceptionally short-lived and possesses a roughly $50\%$ probability of resolving either back into original reactants or forward into products. Because the products occupy a lower free energy state, the reverse transition occurs far less frequently, progressively accumulating products.

  • Activation Energy: The free energy required to reach the transition state constitutes the activation energy barrier. The magnitude of this barrier dictates the kinetics (velocity or rate) of the reaction. Higher activation energies correlate with slower reaction rates because fewer molecules possess sufficient kinetic energy per unit time to reach the barrier.

  • Kinetics vs. Thermodynamics: Kinetics governs reaction velocity; thermodynamics dictates directionality and final equilibrium position. Catalytic acceleration of reaction velocity never alters the thermodynamic free energy change ($\Delta G$) or the final equilibrium constant.

• The Macroscopic Model of Combustion:

  • The combustion of cellulose (paper) in the presence of atmospheric oxygen produces carbon dioxide:         $\text{Cellulose} + O_2 \rightarrow CO_2 + H_2O$

  • Combustion is highly exergonic and energetically favorable, but paper remains stable at room temperature due to a substantial activation energy barrier.

  • Introducing a spark provides localized activation energy to cross the barrier, after which the released reaction energy sustains the combustion chain reaction.

  • Even without an external flame, paper exposed to ambient conditions for $2$ to $3$ years undergoes slow oxidation, turning yellowish-brown. Surviving paper specimens dating back $2,000$ years exist exclusively under specialized preservation conditions that dramatically suppress this slow oxidation process.

Mechanisms of Catalysis: Inorganic Catalysts Versus Enzymes

• Inorganic Catalysts (Platinum):

  • Finely divided platinum ($Pt$) powder acts as a surface catalyst by physically adsorbing reacting molecules onto its lattice in close proximity and optimal orientation.

  • Bringing reactants into near proximity drastically lowers the activation energy barrier by increasing collision frequency, accelerating reaction velocity by roughly $10,000$-fold.

  • Defining Properties of a Catalyst:

    • Participates directly in the chemical pathway by stabilizing the transition state.

    • Emerges chemically unchanged upon completion of the reaction cycle.

    • Increases reaction velocity without modifying the thermodynamic equilibrium or final product-to-reactant ratio (maintains the $150:1$ equilibrium ratio in the $H_2 + I_2$ system).

  • Inorganic platinum lacks substrate selectivity. It is utilized broadly in automobile catalytic converters to oxidize toxic carbon monoxide ($CO$) into carbon dioxide ($CO_2$), and in industrial hydrogenation of polyunsaturated oils.

• Enzymes as Biological Catalysts:

  • Enzymes are specialized catalytic proteins that bind substrates (ligands or reactants) within an active site.

  • The active site comprises a specific substrate binding site and catalytic functional groups (amino acid side chains or metal cofactors) that stabilize the transition state and facilitate covalent transformations.

  • Enzymes release synthesized products and emerge unaltered, prepared for subsequent catalytic rounds.

Structural Basis of Enzyme Specificity and Catalytic Mechanisms

• Catalytic Mechanism of Carboxypeptidase:

  • Carboxypeptidase is an exopeptidase that sequentially hydrolyzes peptide bonds one amino acid at a time starting from the C-terminus of polypeptide substrates.

  • Active Site Organization:

    • An Arginine residue forms electrostatic interactions with the negatively charged terminal carboxylate group ($-COO^-$) of the substrate, anchoring the polypeptide in place.

    • A prosthetic divalent Zinc ion ($Zn^{2+}$), coordinated by three amino acid residues of the enzyme, acts as a Lewis acid to pull on the partially negative carbonyl oxygen ($C=O$) of the scissile peptide bond.

    • A Tyrosine residue presents a hydroxyl group ($-OH$) that forms a hydrogen bond with the peptide bond nitrogen, exerting an additional polarizing pull.

    • These concerted interactions geometrically distort the peptide bond, reducing its covalent stability and rendering it highly susceptible to nucleophilic attack and hydrolysis by a water molecule.

  • Substrate Selectivity and Hydrophobic Pocket:

    • The active site features a large hydrophobic pocket tailored to accommodate bulky, hydrophobic amino acid side chains.

    • Although the generic active site architecture permits cleavage of any C-terminal residue, carboxypeptidase exhibits markedly higher kinetic rates when hydrolyzing residues with bulky, nonpolar side chains due to tighter binding affinity.

• Substrate and Stereochemical Specificity:

  • Unlike broad-spectrum inorganic catalysts like platinum, enzymes demonstrate stringent molecular and stereochemical specificity.

  • Succinate Dehydrogenase Example:

    • Catalyzes the interconversion of succinic acid and fumaric acid (reduction of fumarate to succinate via hydrogenation, or oxidation of succinate to fumarate via dehydrogenation):             $\text{Fumaric acid} + 2H \rightleftharpoons \text{Succinic acid}$

    • Although named for the reverse oxidative reaction, the enzyme catalytically accelerates both directions without dictating thermodynamic preference.

    • Succinate dehydrogenase strictly recognizes fumaric acid, which possesses a trans configuration around its carbon-carbon double bond.

    • The enzyme completely fails to bind or process maleic acid, the cis stereoisomer of fumaric acid, because the carboxyl groups in the cis geometry are improperly positioned to interact with the catalytic amino acid side chains.

  • Chiral Discrimination: Enzymes selectively process $L$-amino acids and cannot incorporate or utilize $D$-amino acids in translation or metabolism due to stereospecific active site geometry.

• Summary of Catalytic Strategies Used by Enzymes:

  • Approximation and orientation: Binding substrates in close proximity with correct alignment.

  • Strain and distortion: Weakening existing covalent bonds via active site side-chain interactions.

  • Direct participation: Promoting nucleophilic attacks, acid-base catalysis, or condensation/polymerization reactions while returning to an unperturbed state post-product release.

Steady State Dynamics Versus Thermodynamic Equilibrium

• Differentiating Steady State from Equilibrium:

  • Thermodynamic Equilibrium: A state occurring exclusively in a closed system characterized by the complete absence of net molecular flux ($\text{Net flux} = 0$). Conceptualized as two connected beakers of water: when opened, liquid levels equalize until no net movement occurs between the vessels.

  • Steady State: A condition characteristic of open systems where internal concentrations remain invariant over time because the rate of material influx exactly equals the rate of material efflux ($\text{Rate in} = \text{Rate out}$, with continuous net flux). Conceptualized as a single open beaker draining liquid while fresh water is added at an identical rate.

  • Biological Application:

    • Living organisms operate exclusively at steady state (homeostasis) and never at thermodynamic equilibrium. Achieving true thermodynamic equilibrium equates to biological death.

    • Living organisms continuously take in nutrients and excrete waste products. Within approximately $10$ years, roughly $99\%$ of all atoms within the human body are completely exchanged with the external environment.

  • The Enzyme-Substrate Complex ($ES$):

    • During initial reaction phases, the concentration of the $ES$ complex remains constant.

    • This constancy represents a steady state rather than an equilibrium: the enzyme continuously binds fresh substrate and discharges product, maintaining an unbroken net flow of chemical matter through the catalytic complex.

Quantitative Enzyme Kinetics: The Michaelis-Menten Framework

• Experimental Determination of Initial Velocity ($v_0$):

  • Enzyme kinetics measures the initial velocity ($v_0$), defined as the rate of product appearance or the rate of substrate disappearance over time at early intervals ($t \approx 0$):         $v_0 = \frac{\Delta [P]}{\Delta t} = -\frac{\Delta [S]}{\Delta t}$

  • At a fixed, constant enzyme concentration ($[E]_0$), product appearance is recorded over time across multiple initial substrate concentrations ($[S]$, e.g., $0.1\,\text{M}$, $0.5\,\text{M}$, and $1.0\,\text{M}$).

  • The initial slope of each progress curve represents $v_0$ for that particular $[S]$.

  • Curve Plateau Mechanisms:

    • In an individual progress curve ($[P]$ versus time), product formation eventually plateaus because substrate becomes completely exhausted.

    • In a kinetic saturation curve ($v_0$ versus $[S]$), velocity plateaus at a maximal limit ($V_{\max}$) because the enzyme molecules become fully saturated with substrate. At high $[S]$, every active site is continuously occupied.

    • An uncatalyzed chemical reaction curve plotted on the same axes is nearly flat, as uncatalyzed rates are $10,000$-fold to $100,000$-fold slower than enzyme-catalyzed rates.

• The Reaction Scheme and Historical Assumptions:

  • Developed over $110$ years ago by Leonor Michaelis and Maud Menten, establishing a quantitative model based on the following reaction mechanism:         $E + S \underset{k_2}{\overset{k_1}{\rightleftharpoons}} ES \underset{k_4}{\overset{k_3}{\rightleftharpoons}} E + P$         Where:

    • $k_1$ is the rate constant for $ES$ complex formation.

    • $k_2$ is the rate constant for $ES$ dissociation back to free enzyme and substrate.

    • $k_3$ is the rate constant for catalytic conversion of $ES$ into free enzyme and product.

    • $k_4$ is the rate constant for the reverse association of enzyme and product.

  • Underlying Assumptions of the Model:

    • Complex Formation: The reaction obligatorily proceeds through an intermediate enzyme-substrate complex ($ES$).

    • Negligible Reverse Product Reaction: Because measurements evaluate initial rates ($v_0$) when product concentration is near zero ($[P] \approx 0$), the reverse reaction represented by $k_4$ is negligible and omitted.

    • Steady-State Approximation: The concentration of $ES$ remains constant over the measurement period, such that the rate of $ES$ formation equals its total rate of breakdown.

• Derivation and Algebraic Simplifications:

  • Accounting for all rate constants:         $v_0 = \frac{k_3 [E]_0 [S]}{\frac{k_2 + k_3}{k_1} + [S]}$

  • The collection of kinetic constants is grouped into a single parameter, the Michaelis constant ($K_m$):         $K_m = \frac{k_2 + k_3}{k_1}$

  • Substituting $K_m$ yields:         $v_0 = \frac{k_3 [E]_0 [S]}{K_m + [S]}$

  • At infinitely high substrate concentration ($[S] \gg K_m$), the reaction reaches its theoretical maximal velocity ($V_{\max}$):         $V_{\max} = k_3 [E]_0$

  • Substituting $V_{\max}$ produces the classical Michaelis-Menten equation:         $v_0 = \frac{V_{\max} [S]}{K_m + [S]}$

• Kinetic Behavior at Limiting Substrate Concentrations:

  • Enzyme Concentration Dependence: Initial velocity scales directly and linearly with total enzyme concentration ($[E]_0$). Doubling $[E]_0$ doubles $v_0$; tripling $[E]_0$ triples $v_0$.

  • Low Substrate Regime ($[S] \ll K_m$):

    • When substrate concentration is negligible relative to $K_m$, the denominator term ($K_m + [S]$) approximates $K_m$.

    • The velocity equation simplifies to:             $v_0 \approx \frac{V_{\max}}{K_m} [S]$

    • Under these conditions, reaction velocity rises linearly as a first-order function of $[S]$.

  • High Substrate Regime ($[S] \gg K_m$):

    • When substrate concentration vastly exceeds $K_m$, the term ($K_m + [S]$) approximates $[S]$.

    • The $[S]$ terms in the numerator and denominator cancel out, simplifying the equation to:             $v_0 \approx V_{\max}$

    • Under saturating conditions, the reaction displays zero-order kinetics and is independent of changes in $[S]$.

  • Intermediate Regime ($[S] \approx K_m$): Velocity curvature decelerates and asymptotically approaches $V_{\max}$.

Kinetic Parameters: Turnover Number ($k_{\text{cat}}$) and Michaelis Constant ($K_m$)

• The Turnover Number ($k_3$ or $k_{\text{cat}}$):

  • Definition: The maximum number of substrate molecules converted into product per molecule of enzyme active site per second when the enzyme is fully saturated:         $k_{\text{cat}} = \frac{V_{\max}}{[E]_0}$

  • Units are expressed in reciprocal seconds ($\text{s}^{-1}$).

  • A turnover number of $20\,\text{s}^{-1}$ signifies that a single enzyme molecule processes $20$ substrate molecules into product every second.

  • Biological Magnitudes Across Enzymes:

    • Succinate Dehydrogenase: Possesses a $k_{\text{cat}}$ of $19\,\text{s}^{-1}$, which falls well below the biological average.

    • Typical Enzymes: Most cellular enzymes exhibit turnover numbers ranging between $100\,\text{s}^{-1}$ and $1,000\,\text{s}^{-1}$.

    • Carbonic Anhydrase: Among the fastest enzymes known, catalyzing the reversible hydration of carbon dioxide ($CO_2 + H_2O \rightleftharpoons H_2CO_3$) with an exceptional $k_{\text{cat}}$ of $600,000\,\text{s}^{-1}$.

  • Evolutionary Calibration of Catalytic Rates: Not all enzymes have evolved toward maximal $k_{\text{cat}}$ values. In the absence of selective pressure for extreme flux, an enzyme need only be fast enough to satisfy physiological metabolic demands.

• The Michaelis Constant ($K_m$):

  • Operational Definition: The specific substrate concentration at which the initial velocity reaches exactly half of its maximal velocity ($v_0 = 0.5 V_{\max}$).

  • Units of $K_m$ are concentration units, typically expressed in molarity ($\text{M}$).

  • Relationship to the Dissociation Constant ($K_d$):

    • The dissociation constant for the binary $ES$ complex is defined as:             $K_d = \frac{k_2}{k_1}$

    • Because $K_m = \frac{k_2 + k_3}{k_1}$, if the catalytic step is substantially slower than substrate unbinding ($k_3 \ll k_2$), then $K_m$ closely approximates the true thermodynamic dissociation constant:             $K_m \approx \frac{k_2}{k_1} = K_d$

    • Analogy: Assembling a pencil and paper to write an essay occurs rapidly and dissociates easily ($k_1$, $k_2$), whereas the subsequent act of composing the full essay ($k_3$) is substantially slower. Thus, for many enzymatic systems, $k_2 \gg k_3$.

    • Caveat: For enzymes with extremely rapid catalytic rates (such as carbonic anhydrase, where $k_3$ is exceptionally high), this assumption is invalid, and $K_m$ cannot be equated with $K_d$.

  • Significance of Affinity:

    • The reciprocal of $K_m$ ($1/K_m$) reflects the apparent association constant ($K_a$).

    • A lower $K_m$ indicates higher binding affinity (the enzyme binds substrate tightly and requires low $[S]$ to achieve saturation).

    • A higher $K_m$ indicates lower binding affinity (the enzyme binds substrate weakly).

  • Physiological Spectrum of $K_m$ Values:

    • High affinity: $K_m \approx 10^{-6}\,\text{M}$.

    • Intermediate affinity: $K_m \approx 10^{-4}\,\text{M}$.

    • Low affinity: $K_m \approx 10^{-3}\,\text{M}$.

    • These affinity values are evolutionarily matched to the actual steady-state substrate concentrations present within specific subcellular compartments.

Mechanisms of Enzyme Inhibition

• Competitive Inhibition:

  • Molecular Mechanism: The competitive inhibitor structurally mimics the native substrate and directly competes for binding within the active site.

  • Kinetic Signatures:

    • Effect on $K_m$: Increases the apparent $K_m$ ($K_m^{\text{apparent}} > K_m$). A higher concentration of substrate is required to achieve half-maximal velocity because a portion of the enzyme pool is occupied by inhibitor.

    • Effect on $V_{\max}$: Does not alter $V_{\max}$. At sufficiently high substrate concentrations, substrate molecules completely outcompete the inhibitor, restoring maximal catalytic velocity.

  • Pharmacological Applications:

    • Synthetic pharmaceutical drugs are predominantly competitive inhibitors designed to match substrate structural templates.

    • Statins in Cholesterol Regulation: Cholesterol is essential for cellular membrane integrity, but excessive levels induce atherosclerotic arterial plaques, triggering myocardial infarctions and cerebrovascular accidents. The body obtains cholesterol through diet and de novo hepatic biosynthesis.

    • Statins feature a functional chemical moiety that closely mimics HMG-CoA, the natural substrate of HMG-CoA reductase (the rate-limiting enzyme of cholesterol synthesis). Binding of statins competitively arrests this pathway, reducing systemic endogenous cholesterol levels.

• Noncompetitive Inhibition:

  • Molecular Mechanism: Noncompetitive inhibitors bind to a site other than the substrate-binding active site (or bind critical residues within or adjacent to the active center) and inactivate the enzyme regardless of whether substrate is bound.

  • Kinetic Signatures:

    • Effect on $V_{\max}$: Decreases $V_{\max}$. Inactivating a fraction of the enzyme pool effectively lowers the active total enzyme concentration ($[E]_0$). Because $V_{\max} = k_3 [E]_0$, reducing functional enzyme concentration lowers maximal velocity proportionally (e.g., if two of six enzyme molecules are chemically inactivated, $V_{\max}$ decreases by one-third).

    • Effect on $K_m$: Leaves $K_m$ unchanged. The remaining uninhibited enzyme molecules retain intact active sites with unperturbed binding affinities for the substrate.

  • Biological and Toxicological Examples:

    • Mercury ($Hg$): Heavy metal poison that binds covalently to sulfhydryl groups of cysteine residues located within or near reactive catalytic centers, causing broad-spectrum enzymatic inactivation. Historically found in clinical fever thermometers, requiring specialized hazmat remediation protocols upon structural breakage.

    • Venoms and Poisons: Many animal venoms function as noncompetitive inhibitors. Because enzymes are present within cells at catalytic trace quantities relative to metabolites, minute quantities of noncompetitive toxins are sufficient to shut down vital physiological functions.

• Allosteric Inhibition:

  • Molecular Mechanism: The term allosteric originates from the Greek for "other site." Allosteric inhibitors bind specifically to a dedicated regulatory site geographically distinct from the catalytic active site.

  • Binding induces a conformational change throughout the protein architecture that transitions the catalytic active site into an inactive or low-affinity state.

  • Allosteric enzymes frequently exhibit quaternary structure, comprising distinct regulatory subunits (which bind allosteric effectors) and catalytic subunits (which house the active sites).

  • Kinetic Impact: Allosteric inhibitors do not follow simple Michaelis-Menten kinetics. Depending on the specific enzyme system, allosteric regulators may alter $K_m$, $V_{\max}$, or both parameters simultaneously.

  • The structure of an allosteric inhibitor typically bears zero structural resemblance to the enzymatic substrate, preventing cross-binding to the catalytic site.

Allosteric Regulation and Metabolic Feedback Control

• Feedback Inhibition Principles:

  • Cells utilize allosteric regulation to execute feedback inhibition (end-product inhibition) over multi-step biosynthetic pathways.

  • When an end product reaches physiologically sufficient concentrations, excess unbound end product acts as an allosteric inhibitor that binds to and shuts down the enzyme catalyzing the first committed step of its dedicated pathway.

  • As end-product concentrations decline through consumption, inhibitor molecules dissociate from allosteric sites, restoring enzymatic activity and pathway flux.

• The Logic of the First Committed Step:

  • The first committed step is the earliest enzymatic step unique to the synthesis of a specific end product.

  • Linear Pathway: In an unbranched pathway converting glucose to alanine, Step $1$ constitutes the dedicated, first committed step, making the initial enzyme the target for feedback regulation by alanine.

  • Branched Pathway Analysis:

    • Consider a divergent metabolic network originating from glucose that splits to generate end products $G$, $J$, and $N$:

    • Inhibition of the universal Step $1$ would prematurely shut down synthesis of all downstream branches, potentially starving the cell of products $J$ and $N$.

    • To regulate end product $G$ selectively without perturbing neighboring branches, the cell targets enzymatic Step $5$ (the first committed step dedicated solely to branch $G$).

    • The first committed step dedicated to end product $J$ is Step $9$.

    • The first committed step dedicated to end product $N$ is Step $10$.

• Isoleucine Biosynthesis Model:

  • The bacterium Escherichia coli synthesizes the nonpolar amino acid isoleucine from the polar amino acid precursor threonine.

  • Because threonine is itself an essential building block directly required for cellular protein synthesis, feedback inhibition cannot target pathways upstream of threonine.

  • The first committed step dedicated solely to isoleucine production is catalyzed by threonine deaminase.

  • Isoleucine serves as a feedback allosteric inhibitor of threonine deaminase, binding to its regulatory site to halt pathway flux when isoleucine levels are high.

• Evolutionary Advantage of Metabolic Regulation:

  • E. coli cultivated in minimal media supplemented exclusively with glucose as a carbon source exhibits a doubling time of approximately $60\,\text{minutes}$, requiring full de novo synthesis of all structural monomers.

  • When transferred to rich media containing yeast extract (providing pre-formed amino acids, lipids, and carbohydrates), internal feedback allosteric inhibition immediately shuts down unnecessary biosynthetic cascades.

  • Liberated from the metabolic and energetic burden of de novo synthesis, E. coli doubling time decreases from $60\,\text{minutes}$ to approximately $20\,\text{minutes}$.

  • Under conditions of exponential growth, this kinetic acceleration confers an immense selective advantage, allowing regulated organisms to outcompete non-regulated competitors rapidly.

Questions & Discussion

• Question on Activation Energy and Reaction Rates:

  • Prompt: Does the lowering of activation energy by a catalyst change the thermal kinetic likelihood for individual molecules, and does it influence the reaction rate?

  • Response: Lowering the activation energy increases the statistical probability that any given molecular collision possesses sufficient thermal energy to achieve the transition state. Bringing reactants into close physical proximity reduces the kinetic barrier, dramatically increasing the reaction rate. However, it exerts zero effect on reaction directionality or thermodynamic equilibrium (e.g., maintaining the $150:1$ product-to-substrate ratio).

• Discussion on Curve Flattening Mechanisms:

  • Prompt: Why does an individual progress curve of product appearance over time flatten out, and why does a Michaelis-Menten plot of initial velocity versus substrate concentration flatten out?

  • Response: The curves flatten due to entirely different biological reasons:

    • In a plot of product formation versus time, the curve plateaus because the initial substrate has been completely consumed.

    • In a Michaelis-Menten plot of $v_0$ versus $[S]$, the curve plateaus because the fixed enzyme pool has become completely saturated with substrate, reaching $V_{\max}$.

• Poll and Dialogue on Thermodynamic Equilibrium Versus Steady State:

  • Poll Question: Is steady state identical to thermodynamic equilibrium, and are living human beings at equilibrium or at steady state?

  • Response & Discussion: Living humans exist in a steady state, not thermodynamic equilibrium. Equilibrium in a living organism occurs only upon death. A student proposed that a system with constant concentrations might be called a "dynamic equilibrium." While that colloquial term is sometimes misused in biology, in strict physical chemistry, equilibrium requires the absolute absence of net flow ($\text{Net flow} = 0$). Systems with equal input and output rates and continuous molecular exchange are properly defined as steady states. For academic examinations, using "equilibrium" to describe steady-state homeostasis is considered incorrect.

• Clarification on Initial Velocity Versus Reaction Rates:

  • Prompt: How is the overall reaction rate related to initial velocity ($v_0$)?

  • Response: Initial velocity ($v_0$) represents the specific initial rate of product formation per unit time (or substrate depletion per unit time) measured immediately after initiating the reaction ($t \approx 0$), expressed in units of molarity per second ($\text{M/s}$).

• Question on Turnover Number with Multiple Reactants:

  • Prompt: Does the turnover number apply to multi-substrate reactions (e.g., three substrates converting to one product)?

  • Response: The turnover number ($k_{\text{cat}}$) reflects the frequency of the completed catalytic conversion cycle per enzyme active site per second. For a multi-substrate reaction, it denotes the number of times the full complement of substrates is successfully converted into product per second.

• Dialogue on Identifying the First Committed Step:

  • Interactive Exercise: In a branched metabolic pathway originating from glucose:

    • For end product $G$, Step $5$ is the correct committed step because inhibiting earlier steps (Steps $1$ through $4$) would deplete common intermediates required for products $J$ and $N$.

    • For end product $J$, the first dedicated step is Step $9$.

    • For end product $N$, the first dedicated step is Step $10$.

• Question on Feedback Inhibitor Identity:

  • Prompt: Is an allosteric feedback inhibitor always the final end product of a pathway, or can pathway intermediates fulfill this regulatory role?

  • Response: Under typical metabolic conditions, the allosteric inhibitor is the terminal end product itself. However, more complex biological regulatory circuits exist where branch-point intermediates function as regulatory signals.